Cargando…
A case of acute exacerbation of chronic spontaneous urticaria due to COVID-19 immediately after omalizumab administration
Autores principales: | Hayama, Koremasa, Izaki, Satoshi, Hayashi, Kentaro, Kurosawa, Yusuke, Yamada, Shiho, Shimizu, Tetsuo, Gon, Yasuhiro, Fujita, Hideki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837585/ https://www.ncbi.nlm.nih.gov/pubmed/36686023 http://dx.doi.org/10.5114/ada.2022.122609 |
Ejemplares similares
-
Successful treatment of intractable chronic spontaneous urticaria with omalizumab in a patient with ovarian cancer
por: Hayama, Koremasa, et al.
Publicado: (2021) -
Relationship between changes in the 7-day urticaria activity score after treatment with omalizumab and the responsiveness of basophils to FcεRI stimulation in patients with chronic spontaneous urticaria
por: Endo, Takahiro, et al.
Publicado: (2020) -
OMALIZUMAB IN TREATMENT-RESISTANT CHRONIC SPONTANEOUS URTICARIA
por: Godse, Kiran V
Publicado: (2011) -
Profile of omalizumab in the treatment of chronic spontaneous urticaria
por: Labrador-Horrillo, Moises, et al.
Publicado: (2015) -
Case Report: Omalizumab for Chronic Spontaneous Urticaria in Pregnancy
por: Liao, Shuang-Lu, et al.
Publicado: (2021)